Lux Venture Partners V, LLC has filed 15 insider transactions across 1 company since February 2026.
Most recent transaction: a purchase of 138888 shares of Eikon Therapeutics, Inc. ($EIKN) on February 04, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Lux Venture Partners V, LLC | Not found | P | Common Stock | 138888 | $18.00 | 138,888.0000 | 0 | 9999.99% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Lux Venture Partners V, LLC | Not found | P | Common Stock | 138888 | $18.00 | 138,888.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2026 | Eikon Therapeutics, Inc. | $EIKN | Lux Venture Partners V, LLC | Not found | C | Common Stock | 2387705 | $0.00 | 2,387,705.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2026 | Eikon Therapeutics, Inc. | $EIKN | Lux Venture Partners V, LLC | Not found | C | Common Stock | 1151540 | $0.00 | 1,290,428.0000 | 0 | 829.11% | 0.00% |
| Feb. 6, 2026 | Eikon Therapeutics, Inc. | $EIKN | Lux Venture Partners V, LLC | Not found | C | Common Stock | 2155765 | $0.00 | 2,294,653.0000 | 0 | 1552.16% | 0.00% |
| Feb. 6, 2026 | Eikon Therapeutics, Inc. | $EIKN | Lux Venture Partners V, LLC | Not found | C | Series A Preferred Stock | 10000000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2026 | Eikon Therapeutics, Inc. | $EIKN | Lux Venture Partners V, LLC | Not found | C | Series A-1 Preferred Stock | 7807026 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2026 | Eikon Therapeutics, Inc. | $EIKN | Lux Venture Partners V, LLC | Not found | C | Series A-1 Preferred Stock | 2502252 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2026 | Eikon Therapeutics, Inc. | $EIKN | Lux Venture Partners V, LLC | Not found | C | Series B Preferred Stock | 796380 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2026 | Eikon Therapeutics, Inc. | $EIKN | Lux Venture Partners V, LLC | Not found | C | Series B Preferred Stock | 530920 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2026 | Eikon Therapeutics, Inc. | $EIKN | Lux Venture Partners V, LLC | Not found | C | Series B-1 Preferred Stock | 5289322 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2026 | Eikon Therapeutics, Inc. | $EIKN | Lux Venture Partners V, LLC | Not found | C | Series B-1 Preferred Stock | 3526215 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2026 | Eikon Therapeutics, Inc. | $EIKN | Lux Venture Partners V, LLC | Not found | C | Series C Preferred Stock | 303360 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2026 | Eikon Therapeutics, Inc. | $EIKN | Lux Venture Partners V, LLC | Not found | C | Series C-1 Preferred Stock | 1450614 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2026 | Eikon Therapeutics, Inc. | $EIKN | Lux Venture Partners V, LLC | Not found | C | Series D Preferred Stock | 10266152 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |